IMM 1.45% 34.0¢ immutep limited

release interim cvac™ clinical data, page-5

  1. 701 Posts.
    Bella,
    Poster presentation is on the 15th of Oct at the International Gynecologic Cancer Society in Vancouver.
    Likely to be made public beforehand via announcement, one assumes.

    ICS data will before the 15th, so either at the same time as interim safety and efficacy data announcement or preceding it.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.